GCL
STLNW

Glazer Capital LLC’s Starling Oncology Warrant STLNW Stock Holding History

Glazer Capital LLC’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-89,888
Closed -$156K – 984
2021
Q2 		$156K Sell
89,888
-10,000
-10% -$13.5K ﹤0.01% 766
2021
Q1 		$135K Hold
99,888
– – ﹤0.01% 675
2020
Q4 		$195K Sell
99,888
-6,800
-6% -$11.7K 0.01% 340
2020
Q3 		$181K Buy
+106,688
New +$175K 0.01% 225

Other funds holding STLNW

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $278M AUM 50.01% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Glazer Capital LLC's STLNW Position: Q3 2021 in Review

Glazer Capital LLC sold out of Starling Oncology Warrant (STLNW) in Q3 2021, closing a stake of 89,888 shares — an estimated $156K sold.

Glazer Capital LLC first reported a position in STLNW in Q3 2020 and held it in 4 quarters. The position peaked at $195K in Q4 2020. 21 funds tracked by Wall St. Rank hold STLNW as of Q3 2021.

  • Glazer Capital LLC reported no remaining Starling Oncology Warrant position as of Q3 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 89,888 Starling Oncology Warrant shares in Q3 2021, an estimated $156K.
  • Glazer Capital LLC first reported a position in Starling Oncology Warrant in Q3 2020 and held it in 4 quarters.
  • Glazer Capital LLC's Starling Oncology Warrant position peaked at $195K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q3 2021.

Based on Glazer Capital LLC's 13F filing for Q3 2021, filed 15 Nov 2021.